Abstract: The technology of the present application provides software as a service (SaaS) executing on a server in a cloud or network. The SaaS receives data from a mobile device of a user over the network. The SaaS processes the data and returns the processed data to a client application executing on a client device of the user, which user is the same as the user of the mobile device wherein there is no direct communication link, wireless or wired, between the mobile device and the client device. In one aspect, the technology of the present application provides the mobile device as a smartphone and a microphone application to be executed on the smartphone.

Abstract: Embodiments include a vehicle turntable comprising a central hub communicatively coupled to a control unit for receiving control signals; a plurality of wedge-shaped panels radially coupled to the central hub so as to form a circular surface; a plurality of wheels coupled to a number of the plurality of panels; and at least one motor configured to drive a corresponding one of the plurality of wheels and to receive the control signals from the central hub. Embodiments also include a system comprising a first turntable hub configured to control operation of a first turntable; and a control unit communicatively coupled to the first turntable hub to provide control signals to the first turntable hub.

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies, e.g., the anti-TNF antibody golimumab having a heavy chain (HC) comprising an amino acid sequence of SEQ ID NO:36 and a light chain (LC) comprising an amino acid sequence of SEQ ID NO:37, for use in the treatment of juvenile idiopathic arthritis (JIA), and in particular for polyarticular juvenile idiopathic arthritis (pJIA).

Abstract: A pressure balanced well flow control system includes a pressure balanced variable orifice flow control having a controlled flow inlet in fluid communication with a subterranean well and a balance pressure inlet in fluid communication with an outlet end of a fluid pressure isolator. An inlet end of the fluid pressure isolator is in fluid communication with the subterranean well.

Abstract: Apparatus and methods are disclosed for assembling a multi-well fracturing system, and components useful in such a system, and for performing fracturing operations. The multi-well fracturing systems include a skid-based connection assembly including a movable conduit as a switching member between multiple branches of the fracturing system which extend to different wells within the system. Some such systems may include one or more components placed on adjustable skids to facilitate assembly of the fracturing system.

Abstract: A compensating fastener assembly is configured to secure a fastener to a surface element. The compensating fastener assembly includes a compression limiter having a cylindrical main body and a flange, the cylindrical main body defining a channel and a longitudinal axis. The compensating fastener assembly further includes a spring defining a central passage. The central passage of the spring is configured to receive the main body of the compression limiter such that a first end of the spring is configured to be disposed adjacent the flange of the compression limiter.

Abstract: A system and method for facilitating annotation of a digital document between first and second computing devices is provided. The system comprises a database/server that receives the digital document from the first computing device and communicates the digital document to the second computing device. The second computing device receives and displays the digital document for annotation. The annotation produces an annotated digital document which includes the original document data and annotated document data overlaying the original document without modification to the original document data.

Abstract: The present invention relates to compositions and methods utilizing anti-TNF antibodies, e.g., the anti-TNF antibody golimumab having a heavy chain (HC) comprising an amino acid sequence of SEQ ID NO:36 and a light chain (LC) comprising an amino acid sequence of SEQ ID NO:37, for use in the treatment of juvenile idiopathic arthritis (JIA), and in particular for polyarticular juvenile idiopathic arthritis (pJIA).

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. The verifying party stores the self-signed certificate with user identification data. The user migrates trust to another device by providing the root certificate and intermediate certificate as a certificate chain to a second device, which then adds a new intermediate certificate to create a longer certificate chain with the same root certificate. In subsequent communications, the verifying party receives a certificate chain including the self-signed certificate from the second user device, and matches that with the user identification data stored in a database.

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. The verifying party stores the self-signed certificate with user identification data, including at least one of a user name, user address, user email, user phone number, user tax ID, user social security number and user financial account number. In subsequent communications, the verifying party receives a certificate chain including the self-signed certificate, and matches that with the user identification data stored in a database.

Abstract: A system includes at least a secure-boot file, a hypervisor, and a host. The secure-boot file is configured to securely boot a VM, where the secure-boot file is signed with a boot private key. The hypervisor is configured to run the VM. The hypervisor includes a boot public key corresponding to the boot private key, such that the hypervisor is configured to validate the secure-boot file, and the hypervisor is signed with a hypervisor private key. A kernel of the host is configured to run the VM, where the kernel includes a hypervisor public key corresponding to the hypervisor private key, such that the host is configured to validate the hypervisor.

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. The verifying party stores the self-signed certificate with user identification data, including at least one of a user name, user address, user email, user phone number, user tax identification (ID), user social security number and user financial account number. In subsequent communications, the verifying party receives a certificate chain including the self-signed certificate, and matches that with the user identification data stored in a database.

Abstract: A pressure balanced well flow control system includes a pressure balanced variable orifice flow control having a controlled flow inlet in fluid communication with a subterranean well and a balance pressure inlet in fluid communication with an outlet end of a fluid pressure isolator. An inlet end of the fluid pressure isolator is in fluid communication with the subterranean well.

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. The verifying party stores the self-signed certificate with user identification data. The user migrates trust to another device by providing the root certificate and intermediate certificate as a certificate chain to a second device, which then adds a new intermediate certificate to create a longer certificate chain with the same root certificate. In subsequent communications, the verifying party receives a certificate chain including the self-signed certificate from the second user device, and matches that with the user identification data stored in a database.

Abstract: A bushing device includes a cap end shaped to engage a first surface of a first component having a first hole, and a slotted barrel body coupled with the cap end and elongated along a center axis. The slotted barrel body includes plural first cantilevered beam legs extending away from the cap end in directions that are parallel to the center axis. One or more of the first cantilevered beam legs has a hook at a distal end of the one or more first cantilevered beam legs. The slotted barrel body is shaped to fit inside the first hole in the first component and into a concentric second hole in a second component. The hook of the one or more first cantilevered beam legs is positioned to engage the second component to secure the first component and the second component together.

Abstract: Various methods and systems are provided for a flexible, lightweight, low-cost radio frequency (RF) coil array of a magnetic resonance imaging (MRI) system. In one example, a RF coil array for a MRI system includes a plurality of RF coils, each RF coil comprising an integrated capacitor coil loop; a plurality of coupling electronics units each coupled to a respective coil loop; and a plurality of wires coupling each coupling electronics unit to an interface board configured to couple to a cable of the MRI system. The RF coil array is a high density (referring to the number of coil elements) anterior array (HDAA) or a high definition (referring to image resolution) anterior array.

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. A redirecting module redirects the self-signed certificate chain to an authentication server. The authentication server is also provided a user name, password and verifying computer address, which is stored in a password database by the authentication server, in association with the self-signed certificate. Subsequent communications intended for the verifying computer with the self-signed certificate are redirected to the authentication server, which looks up the associated user name and password and transmits the associated user name and password to the verifying computer.

Abstract: In embodiments, an authentication server interfaces between a user device with a self-signed certificate and a verifying computer that accepts a user name and password. The user device generates a self-signed certificate signed by a private key on the user device. The self-signed certificate is transmitted to a verifying party computer over a network. The verifying party stores the self-signed certificate with user identification data, including at least one of a user name, user address, user email, user phone number, user tax identification (ID), user social security number and user financial account number. In subsequent communications, the verifying party receives a certificate chain including the self-signed certificate, and matches that with the user identification data stored in a database.

Abstract: The present invention provides compounds of Formula I?, or pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and methods of use thereof for treating cellular proliferative disorders (e.g., cancer).